Effect of Acupoint Catgut Embedding for Middle-Aged Obesity: A Multicentre, Randomised, Sham-Controlled Trial

Table 5

Reduction in waistline from baseline (cm) based on intention-to-treat principle.

Time point	Reduction from baseline (cm); Adjusted mean (95% confidence interval),			Mixed-effects model using visit as continuous variable; Coefficient (95% confidence interval),
	ACE group	Sham ACE group	Difference	Group	Time	Group^a Time
4 weeks	−1.83 (−2.43, −1.24), <0.001	−1.64 (−2.25, −1.04), <0.001	−0.19 (−1.03, 0.65), 0.655
8 weeks	−4.08 (−4.81, −3.35), <0.001	−2.75 (−3.47, −2.04), <0.001	−1.33 (−2.35, −0.30), 0.011
12 weeks	−5.80 (−6.59, −5.00), <0.001	−3.57 (−4.36, −2.78), <0.001	−2.23 (−3.35, −1.11), <0.001
16 weeks	−8.21 (−9.02, −7.40), <0.001	−3.81 (−4.66, −2.96), <0.001	−4.40 (−5.56, −3.24), <0.001	−0.83 (−2.43, 0.77), 0.308	−0.01 (−0.03, 0.01), 0.233	−0.07 (−0.10, −0.04), <0.001
28 weeks	−7.95 (−8.76, −7.13), <0.001	−3.76 (−4.60, −2.91), <0.001	−4.19 (−5.37, −3.01), <0.001
40 weeks	−7.95 (−8.83, −7.06), <0.001	−3.29 (−4.20, −2.39), <0.001	−4.66 (−5.93, −3.38), <0.001
Overall	−5.97 (−10.61, −1.33), 0.013	−3.14 (−4.78, −1.50), <0.001	−2.83 (−3.78, −1.89), <0.001

Change from baseline: after value (posttreatment)–before value (baseline).